Canton Strategic Holdings, Inc. (NASDAQ:CNTN) — Market Cap & Net Worth
Market Cap & Net Worth: Canton Strategic Holdings, Inc. (CNTN)
Canton Strategic Holdings, Inc. (NASDAQ:CNTN) has a market capitalization of $187.08 Million ($187.08 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #16902 globally and #3940 in its home market, demonstrating a 32.09% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Canton Strategic Holdings, Inc.'s stock price $3.54 by its total outstanding shares 69804880 (69.80 Million). Review CNTN total debt and obligations to assess the company's total debt and financial obligations.
Canton Strategic Holdings, Inc. Market Cap History: 2026 to 2026
Canton Strategic Holdings, Inc.'s market capitalization history from 2026 to 2026. Data shows growth from $247.11 Million to $247.11 Million (0.00% CAGR).
Canton Strategic Holdings, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Canton Strategic Holdings, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CNTN by Market Capitalization
Companies near Canton Strategic Holdings, Inc. in the global market cap rankings as of June 18, 2026.
Key companies related to Canton Strategic Holdings, Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #444 globally with a market cap of $62.63 Billion USD.
- UCB SA (BR:UCB): Ranked #549 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #573 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #222 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $458.99 |
| #444 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $62.63 Billion | $607.93 |
| #549 | UCB SA | BR:UCB | $49.68 Billion | €252.40 |
| #573 | Argen-X | BR:ARGX | $47.14 Billion | €780.20 |
Canton Strategic Holdings, Inc. Historical Marketcap From 2026 to 2026
Between 2026 and today, Canton Strategic Holdings, Inc.'s market cap moved from $247.11 Million to $ 247.11 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $247.11 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Canton Strategic Holdings, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $187.08 Million USD |
| MoneyControl | $187.08 Million USD |
| MarketWatch | $187.08 Million USD |
| marketcap.company | $187.08 Million USD |
| Reuters | $187.08 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Canton Strategic Holdings, Inc.
Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States. It operates in two segments, Digital Asset Treasury and Clinical Stage Bio-technology. The company is involved in the operation of Canton Coin-centric digital asset treasury strategies, including validator operations and network participation; application su… Read more